Mitochondrial uncoupling proteins in the CNS: In support of function and survival

Nature Reviews Neuroscience

Volumn 6, Issue 11, 2005, Pages 829-840

  Andrews, Zane B ^a   Diano, Sabrina ^a   Horvath, Tamas L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; CALCIUM; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; CARRIER PROTEIN; FATTY ACID; FREE RADICAL; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; PICRIC ACID; QUINOLINIC ACID; SUPEROXIDE; UBIDECARENONE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 4; UNCOUPLING PROTEIN 5;

AGING; ALPHA HELIX; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BIOGENESIS; BODY TEMPERATURE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CELL DAMAGE; CELL FUNCTION; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM FUNCTION; CEREBELLUM; DOPAMINE RELEASE; EPILEPSY; EXCITOTOXICITY; HIPPOCAMPUS; HUMAN; LONGEVITY; MITOCHONDRIAL MEMBRANE; NERVE CELL; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PAIN; PANCREAS ISLET BETA CELL; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SURVIVAL; SYNAPSE; SYNAPTOSOME; THERMOGENESIS;

ANIMALS; CARRIER PROTEINS; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; HUMANS; ION CHANNELS; MEMBRANE PROTEINS; MITOCHONDRIAL PROTEINS; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; NEURONS; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 27644448810     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn1767     Document Type: Review

References (103)

1. Krauss, S., Zhang, C. Y. & Lowell, B. B. The mitochondrial uncoupling-protein homologues. Nature Rev. Mol. Cell Biol. 6, 248-261 (2005). An up-to-date review on the biochemical regulation of UCPs.
2. Nicholls, D. G. & Locke, R. M. Thermogenic mechanisms in brown fat. Physiol. Rev. 64, 1-64 (1984). Seminal review on the actions of UCP1 in brown adipose tissue.
3. Cannon, B. & Nedergaard, J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84, 277-359 (2004).
4. Skulachev, V. P. Uncoupling: new approaches to an old problem of bioenergetics. Biochim. Biophys. Acta 1363, 100-124 (1998).
5. Fleury, C. et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nature Genet. 15, 269-272 (1997).
6. Boss, O. et al. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett. 408, 39-42 (1997).
7. Mao, W. et al. UCP4, a novel brain-specific mitochondrial protein that reduces membrane potential in mammalian cells. FEBS Lett. 443, 326-330 (1999).
8. Sanchis, D. et al. BMCP1, a novel mitochondrial carrier with high expression in the central nervous system of humans and rodents, and respiration uncoupling activity in recombinant yeast. J. Biol. Chem. 273, 34611-34615 (1998). References 5, 7 and 8 are the original papers describing the discovery of UCP2, UCP4 and BMCP1/UCP5.
9. Miroux, B., Frossard, V., Raimbault, S., Ricquier, D. & Bouillaud, F. The topology of the brown adipose tissue mitochondrial uncoupling protein determined with antibodies against its antigenic sites revealed by a library of fusion proteins. EMBO J. 12, 3739-3745 (1993).
10. Saier, M. H. Jr. Vectorial metabolism and the evolution of transport systems. J. Bacteriol. 182, 5029-5035 (2000).
11. Richard, D. et al. Distribution of the uncoupling protein 2 mRNA in the mouse brain. J. Comp. Neurol. 397, 549-560 (1998).
12. Richard, D., Clavel, S., Huang, Q., Sanchis, D. & Ricquier, D. Uncoupling protein 2 in the brain: distribution and function. Biochem. Soc. Trans. 29, 812-817 (2001).
13. Diano, S. et al. Mitochondrial uncoupling protein 2 (UCP2) in the nonhuman primate brain and pituitary. Endocrinology 141, 4226-4638 (2000).
14. Horvath, T. L. et al. Brain uncoupling protein 2: uncoupled neuronal mitochondria predict thermal synapses in homeostatic centers. J. Neurosci. 19, 10417-10427 (1999). Illustrates hypothalamic expression of UCP2 protein and establishes the putative role of UCP2 in producing local temperature gradients that may enhance synaptic function.
15. Horvath, T. L. et al. Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease. Endocrinology 144, 2757-2760 (2003).
16. Kim-Han, J. S., Reichert, S. A., Quick, K. L. & Dugan, L. L. BMCP1: a mitochondrial uncoupling protein in neurons which regulates mitochondrial function and oxidant production. J. Neurochem. 79, 658-668 (2001).
17. Yamada, S., Isojima, Y., Yamatodani, A. & Nagai, K. Uncoupling protein 2 influences dopamine secretion in PC12h cells. J. Neurochem. 87, 461-469 (2003).
18. Zhang, C. Y. et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105, 745-755 (2001).
19. Arsenijevic, D. et al. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nature Genet. 26, 435-439 (2000).
20. Fuxe, K. et al. Dynamics of volume transmission in the brain. Focus on catecholamine and opioid peptide communication and the role of uncoupling protein 2. J. Neural Transm. 112, 65-76 (2005).
21. Nicholls, D. G. & Ward, M. W. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci. 23, 166-174 (2000).
22. Stout, A. K., Raphael, H. M., Kanterewicz, B. I., Klann, E. & Reynolds, I. J. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nature Neurosci. 1, 366-373 (1998). Shows that mitochondrial uncoupling agents reduce the mitochondrial membrane potential, decrease calcium overload and prevent glutamatergic neuronal death.
23. Teshima, Y., Akao, M., Jones, S. P. & Marban, E. Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ. Res. 93, 192-200 (2003).
24. Diano, S. et al. Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. Endocrinology 144, 5014-5021 (2003). Provides the first experimental indication that sustained elevated mitochondrial uncoupling triggers mitochondrial proliferation in which elevated ATP levels are associated with decreased free radical-induced damage. Therefore, cells are better prepared to withstand toxic insults.
25. Garcia-Martinez, C. et al. Overexpression of UCP3 in cultured human muscle lowers mitochondrial membrane potential, raises ATP/ADP ratio, and favors fatty acid vs. glucose oxidation. FASEB J. 15, 2033-2035 (2001).
26. Andrews, Z. B. et al. Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease. J. Neurosci. 25, 184-191 (2005). The first report to show that UCP2-knockout mice are predisposed, whereas animals that overexpress UCP2are resistant, to nigral neurodegeneration, probably owing to alterations in buffering in vivo ROS production.
27. Rossmeisl, M. et al. Expression of the uncoupling protein 1 from the aP2 gene promoter stimulates mitochondrial biogenesis in unilocular adipocytes in vivo. Eur. J. Biochem. 269, 19-28 (2002).
28. Wu, Z. et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115-124 (1999). Shows that PGC1 stimulates mitochondrial biogenesis and respiration through induction of UCP2.
29. Wisloff, U. et al. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 307, 418-420 (2005).
30. Korshunov, S. S., Skulachev, V. P. & Starkov, A. A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 416, 15-18 (1997).
31. Sullivan, P. G., Dube, C., Dorenbos, K., Steward, O. & Baram, T. Z. Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann. Neurol. 53, 711-717 (2003).
32. Negre-Salvayre, A. et al. A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J. 11, 809-815 (1997).
33. Mattson, M. P. & Liu, D. Mitochondrial potassium channels and uncoupling proteins in synaptic plasticity and neuronal cell death. Biochem. Biophys. Res. Commun. 304, 539-549 (2003).
34. Mattiasson, G. et al. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nature Med. 9, 1062-1068 (2003). The first study to show that UCP2 provides neuroprotection against stroke and ischaemic insults. The results also suggest that UCP2 has the ability to channel ROS from the mitochondrial matrix to the cytosol, where they can be neutralized by antioxidants.
35. Pecqueur, C. et al. Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J. Biol. Chem. 276, 8705-8712 (2001).
36. Voehringer, D. W. et al. Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. Proc. Natl Acad. Sci. USA 97, 2680-2685 (2000).
37. Echtay, K. S. et al. Superoxide activates mitochondrial uncoupling proteins. Nature 415, 96-99 (2002).
38. Echtay, K. S., Murphy, M. P., Smith, R. A., Talbot, D. A. & Brand, M. D. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J. Biol. Chem. 277, 47129-47135 (2002).
39. Echtay, K. S. et al. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J. 22, 4103-4110 (2003).
40. Couplan, E. et al. No evidence for a basal, retinoic, or superoxide-induced uncoupling activity of the uncoupling protein 2 present in spleen or lung mitochondria. J. Biol. Chem. 277, 26268-26275 (2002). References 37-40 debate the role of superoxide and markers of oxidative damage as regulators of UCP function.
41. Mattson, M. P. Pathways towards and away from Alzheimer's disease. Nature 430, 631-639 (2004).
42. Aihara, H., Okada, Y. & Tamaki, N. The effects of cooling and rewarming on the neuronal activity of pyramidal neurons in guinea pig hippocampal slices. Brain Res. 893, 36-45 (2001).
43. Yu, X. X. et al. Characterization of novel UCP5/BMCP1 isoforms and differential regulation of UCP4 and UCP5 expression through dietary or temperature manipulation. FASEB J. 14, 1611-1618 (2000).
44. Masino, S. A. & Dunwiddie, T. V. Temperature-dependent modulation of excitatory transmission in hippocampal slices is mediated by extracellular adenosine. J. Neurosci. 19, 1932-1939 (1999).
45. Scarpace, P. J., Matheny, M., Borst, S. & Turner, N. Thermoregulation with age: role of thermogenesis and uncoupling protein expression in brown adipose tissue. Proc. Soc. Exp. Biol. Med. 205, 154-161 (1994).
46. Smythies, J. Redox mechanisms at the glutamate synapse and their significance: a review. Eur. J. Pharmacol. 370, 1-7 (1999).
47. Li, Z., Okamoto, K., Hayashi, Y. & Sheng, M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119, 873-887 (2004).
48. Horvath, B., Spies, C., Warden, C. H., Diano, S. & Horvath, T. L. Uncoupling protein 2 in primary pain and temperature afferents of the spinal cord. Brain Res. 955, 260-263 (2002).
49. Morris, R., Cheunsuang, O., Stewart, A. & Maxwell, D. Spinal dorsal horn neurone targets for nociceptive primary afferents: do single neurone morphological characteristics suggest how nociceptive information is processed at the spinal level. Brain Res. Brain Res. Rev. 46, 173-190 (2004).
50. Horvath, B. et al. Uncoupling protein 2 (UCP2) lowers alcohol sensitivity and pain threshold. Biochem. Pharmacol. 64, 369-374 (2002).
51. Ding, Y., Cesare, P., Drew, L., Nikitaki, D. & Wood, J. N. ATP, P2X receptors and pain pathways. J. Auton. Nerv. Syst. 81, 289-294 (2000).
52. Mogil, J. S. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc. Natl Acad. Sci. USA 96, 7744-7751 (1999).
53. Henshall, D. C. & Simon, R. P. Epilepsy and apoptosis pathways. J. Cereb. Blood Flow Metab. 11 May 2005 (doi:10.1038/sj.jcbfm.9600149).
54. Patel, M., Day, B. J., Crapo, J. D., Fridovich, I. & McNamara, J. O. Requirement for superoxide in excitotoxic cell death. Neuron 16, 345-355 (1996).
55. Reynolds, I. J. & Hastings, T. G. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J. Neurosci. 15, 3318-3327 (1995).
56. Schulz, J. B. et al. Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. 64, 2239-2247 (1995).
57. Billups, B. & Forsythe, I. D. Presynaptic mitochondrial calcium sequestration influences transmission at mammalian central synapses. J. Neurosci. 22, 5840-5847 (2002).
58. Nicholls, D. G. & Budd, S. L. Mitochondria and neuronal glutamate excitotoxicity. Biochim. Biophys. Acta 1366, 97-112 (1998).
59. Maragos, W. F., Rockich, K. T., Dean, J. J. & Young, K. L. Pre- or post-treatment with the mitochondrial uncoupler 2,4-dinitrophenol attenuates striatal quinolinate lesions. Brain Res. 966, 312-316 (2003).
60. Bagetta, G. et al. Abnormal expression of neuronal nitric oxide synthase triggers limbic seizures and hippocampal damage in rat. Biochem. Biophys. Res. Commun. 291, 255-260 (2002).
61. Bellissimo, M. I. et al. Superoxidedismutase, glutathione peroxidase activities and the hydroperoxide concentration are modified in the hippocampus of epileptic rats. Epilepsy Res. 46, 121-128 (2001).
62. Gupta, R. C., Milatovic, D. & Dettbarn, W. D. Nitric oxide modulates high-energy phosphates in brain regions of rats intoxicated with diisopropylphosphorofluoridate or carbofuran: prevention by N-tert-butyl-alpha- phenylnitrone or vitamin E. Arch. Toxicol. 75, 346-356 (2001).
63. Blumcke, I. et al. Cellular pathology of hilar neurons in Ammon's horn sclerosis. J. Comp. Neurol. 414, 437-453 (1999).
64. Clavel, S., Paradis, E., Ricquier, D. & Richard, D. Kainic acid upregulates uncoupling protein-2 mRNA expression in the mouse brain. Neuroreport 14, 2015-2017 (2003).
65. Schauwecker, P. E. & Steward, O. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc. Natl Acad. Sci. USA 94, 4103-4108 (1997).
66. Sullivan, P. G., Springer, J. E., Hall, E. D. & Scheff, S. W. Mitochondrial uncoupling as a therapeutic target following neuronal injury. J. Bioenerg. Biomembr. 36, 353-356 (2004).
67. Nevo, Y. et al. Unprovoked seizures and developmental disabilities: clinical characteristics of children referred to a child development center. Pediatr. Neurol. 13, 235-241 (1995).
68. Hauser, W. A. The prevalence and incidence of convulsive disorders in children. Epilepsia 35 (Suppl. 2), S1-S6 (1994).
69. Dal-Pizzol, F. et al. Lipid peroxidation in hippocampus early and late after status epilepticus induced by pilocarpine or kainic acid in Wistar rats. Neurosci. Lett. 291, 179-182 (2000).
70. Sullivan, P. G. et al. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann. Neurol. 55, 576-580 (2004).
71. Conti, B. et al. Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyltetrahydropyridine toxicity. J. Neurochem. 93, 493-501 (2005).
72. Duan, W. & Mattson, M. P. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 57, 195-206 (1999).
73. Beal, M. F., Matthews, R. T., Tieleman, A. & Shults, C. W. Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res. 783, 109-114 (1998).
74. Shults, C. W. et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch. Neurol. 59, 1541-1550 (2002).
75. Thiruchelvam, M. et al. Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. Eur. J. Neurosci. 18, 589-600 (2003).
76. + neurotoxicity in cerebellar granule cells by antioxidants. Cell Biol. Int. 28, 373-380 (2004).
77. McCarthy, S., Somayajulu, M., Sikorska, M., Borowy-Borowski, H. & Pandey, S. Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10. Toxicol. Appl. Pharmacol. 201, 21-31 (2004).
78. Bechmann, I. et al. Brain mitochondrial uncoupling protein 2 (UCP2): a protective stress signal in neuronal injury. Biochem. Pharmacol. 64, 363-367 (2002). Provided the first in vivo experimental evidence that UCP2 may function as a neuroprotector in the brain.
79. Sullivan, P. G., Keller, J. N., Mattson, M. P. & Scheff, S. W. Traumatic brain injury alters synaptic homeostasis: implications for impaired mitochondrial and transport function. J. Neurotrauma 15, 789-798 (1998).
80. Sullivan, P. G. et al. Exacerbation of damage and altered NF-κB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J. Neurosci. 19, 6248-6256 (1999).
81. de Bilbao, F. et al. Resistance to cerebral ischemic injury in UCP2 knockout mice: evidence for a role of UCP2 as a regulator of mitochondrial glutathione levels. J. Neurochem. 89, 1283-1292 (2004).
82. Ross, C. A. & Poirier, M. A. Protein aggregation and neurodegenerative disease. Nature Med. 10 (Suppl.), S10-S17 (2004).
83. Watson, G. S. & Craft, S. The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment. CNS Drugs 17, 27-45 (2003).
84. Blass, J. P. Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia? J. Neurosci. Res. 66, 851-856 (2001).
85. Hand, C. K. & Rouleau, G. A. Familial amyotrophic lateral sclerosis. Muscle Nerve 25, 135-159 (2002).
86. Rosen, D. R. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62 (1993).
87. Menzies, F. M., Ince, P. G. & Shaw, P. J. Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem. Int. 40, 543-551 (2002).
88. Balaban, R. S., Nemoto, S. & Finkel, T. Mitochondria, oxidants, and aging. Cell 120, 483-495 (2005).
89. Harman, D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11, 298-300 (1956).
90. Dauer, W. & Przedborski, S. Parkinson's disease: mechanisms and models. Neuron 39, 889-909 (2003).
91. Horvath, T. L. et al. Uncoupling proteins-2 and 3 influence obesity and inflammation in transgenic mice. Int. J. Obes. 27, 433-442 (2003).
92. Fridell, Y. W., Sanchez-Blanco, A., Silvia, B. A. & Helfand, S. L. Targeted expression of the human uncoupling protein 2 (hUCP2) to adult neurons extends life span in the fly. Cell Metab. 1, 145-152 (2005). The first study to show that neuron-specific UCP2 promotes longevity, through a reduction in oxidative stress, without compromising fertility or physical activity.
93. Speakman, J. R. et al. Uncoupled and surviving: individual mice with high metabolism have greater mitochondrial uncoupling and live longer. Aging Cell 3, 87-95 (2004).
94. Brand, M. D. Uncoupling to survive? The role of mitochondrial inefficiency in ageing. Exp. Gerontol. 35, 811-820 (2000). First formulation of the hypothesis that enhanced uncoupled respiration promotes longevity.
95. + transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone). Proc. Natl Acad. Sci. USA 98, 1416-1421 (2001).
96. Echtay, K. S., Winkler, E. & Klingenberg, M. Coenzyme Q is an obligatory cofactor for uncoupling protein function. Nature 408, 609-613 (2000).
97. Esteves, T. C. & Brand, M. D. The reactions catalysed by the mitochondrial uncoupling proteins UCP2 and UCP3. Biochim. Biophys. Acta 1709, 35-44 (2005).
98. Jaburek, M. et al. Transport function and regulation of mitochondrial uncoupling proteins 2 and 3. J. Biol. Chem. 274, 26003-26007 (1999).
99. Echtay, K. S. et al. Regulation of UCP3 by nucleotides is different from regulation of UCP1. FEBS Leff. 450, 8-12 (1999).
100. Jaburek, M. & Garlid, K. D. Reconstitution of recombinant uncoupling proteins: UCP1, -2, and -3 have similar affinities for ATP and are unaffected by coenzyme Q10. J. Biol. Chem. 278, 25825-25831 (2003).
101. Brand, M. D. & Esteves, T. C. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab. 2, 85-93 (2005).
102. Garlid, K. D., Jaburek, M. & Jezek, P. Mechanism of uncoupling protein action. Biochem. Soc. Trans. 29, 803-806 (2001).
103. Sivitz, W. I., Fink, B. D. & Donohoue, P. A. Fasting and leptin modulate adipose and muscle uncoupling protein: divergent effects between messenger ribonucleic acid and protein expression. Endocrinology 140, 1511-1519 (1999).